Scientists test if brain tumor drug gets where it needs to go
Knowledge-focused
Terminated
This early study aimed to see if an oral drug called infigratinib could reach brain tumors in patients with a specific genetic change. A small group of adults with recurrent high-grade glioma took the drug before their scheduled tumor removal surgery. Researchers then measured ho…
Phase: EARLY_PHASE1 • Sponsor: Nader Sanai • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:29 UTC